MIR4326

Across TCGA pan-cancer cohorts, MIR4326 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated MIR4326 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher MIR4326 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR4326 expression acts as an unfavorable survival marker, although some lineages such as UCS and LAML show a favorable association.

KIRC, UCEC, and THCA are the cancer types where MIR4326 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	All	0.442	0.711	<.001	48	view →
UCEC	DFS	Quartile	All	0.840	0.916	<.001	42	view →
THCA	DFS	Tertile	All	0.829	0.953	.002	34	view →
ACC	DFS	Median	III,IV	0.151	0.543	.001	27	view →
LGG	DFS	Median	All	0.763	0.885	<.001	26	view →
UCS	DFS	Median	IV	0.952	0.367	.001	24	view →
LAML	DFS	Median	All	0.713	0.417	.004	18	view →
HNSC	OS	Median	II,III,IV	0.808	0.703	.022	18	view →
ESCA	DFS	Median	All	0.619	0.452	.013	16	view →
COAD	DFS	Tertile	All	0.633	0.833	.002	16	view →
PRAD	DFS	Median	All	0.738	0.820	.006	14	view →
SKCM	OS	Tertile	IV	1.000	0.234	.020	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

MIR4326–KIRC (DFS)

Open the KIRC breakdown →